MDRX — Veradigm Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid Cap

Annual income statement for Veradigm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,503	1,503	588	626	594
Cost of Revenue
Gross Profit	566	620	308	342	302
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,635	1,417	623	596	807
Operating Profit	-132	85.6	-34.7	30.3	-213
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-149	162	-63.9	60.2	-222
Provision for Income Taxes
Net Income After Taxes	-133	134	-20	49.5	-292
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	700	134	-86.5	49.2	-292
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	700	134	-86.5	49.2	-292
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.52	0.987	-0.088	0.425	-1.94